The prognostic significance of a previous malignancy in operable non-small cell lung cancer

Lung Cancer

Volumn 32, Issue 1, 2001, Pages 47-53

  Koppe, Manuel J ^a   Zoetmulder, Frans A N ^a   Van Zandwijk, Nico ^a   Hart, Augustinus A M ^a   Baas, Paul ^a   Rutgers, Emiel J Th ^a  

^a ANTONI VAN LEEUWENHOEK HOSPITAL   (Netherlands)

Author keywords

Non small cell lung cancer; Prognosis; Second primary malignancy

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER SIZE; CANCER STAGING; CANCER SURVIVAL; CLINICAL FEATURE; DIGESTIVE SYSTEM CANCER; FEMALE; FOLLOW UP; HUMAN; LUNG METASTASIS; LUNG NON SMALL CELL CANCER; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PATHOLOGY; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SECOND CANCER; SEX DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM STAGING; NEOPLASMS; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RADIOTHERAPY, ADJUVANT; SMOKING; SURVIVAL ANALYSIS;

EID: 0035103451     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(00)00208-7     Document Type: Article

References (12)

1. Synchronous and metachronous head and neck carcinomas
2. Association of bronchial and pharyngo-laryngeal malignancies. A reappraisal
3. Survival following resection for lung cancer as a second primary cancer
4. Revisions in the international system for staging lung cancer
5. Increased risk of lung cancer, non-Hodgkin's lymphoma, and leukemia following Hodgkin's disease
6. Second cancer risk following Hodgkin's disease: a 20-year follow-up study
7. Roles of radiotherapy and smoking in lung cancer following Hodgkin's disease
8. Lung cancer after radiotherapy for breast cancer
9. Increased risk of lung cancer after breast cancer radiation therapy in cigarette smokers
10. Lung cancer risk and radiation dose among women treated for breast cancer
11. Clinical study on lung cancer as a second primary cancer
12. Length and lead time biases in radiologic screening for lung cancer